Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-141-8 | CAS number: 7440-31-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 9 January 2009 to 9 March 2009; analyses completed on 03 September 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
- Objective of study:
- excretion
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The purpose of the study was to characterise the routes and rates of excretion of tin in urine and faeces following a single oral administration of elemental tin, using ICP-MS and ICP-AES techniques.
- GLP compliance:
- yes
Test material
- Reference substance name:
- Tin
- EC Number:
- 231-141-8
- EC Name:
- Tin
- Cas Number:
- 7440-31-5
- Molecular formula:
- Sn
- IUPAC Name:
- tin
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material (as cited in study report): Elemental tin powder (2-11 µm)
- Substance type: metallic tin powder
- Physical state: powder
- Analytical purity: 99.97 %
- Lot/batch No.: 070402
- Expiration date of the lot/batch: 5 March 2009
- Stability under test conditions: stable at room temperature
- Storage condition of test material: room temperature 15-25 °C
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- Sprague-Dawley Crl: SD (CD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Ltd, Margate, Kent
- Weight at study initiation: 190-213 g males and 181 to 202 g females
- Housing: Group housed - up to 5 rats per sex in solid floor polycarbonate cages prior to dosing/collection of excreta
- Individual metabolism cages: yes for duration of excreta collection post-dosing in all glass metabolism cages.
- Diet: ad libitum, commercial pelletd diet SQC Rat and Mouse Maintenance Diet No 1, Expanded (Special Diets Services)
- Water: ad libitum, mains drinking water supplied by cage bottles.
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature:19-25 °C
- Humidity: 40-70 % RH
- Air changes: (15 minimum) per hr
- Photoperiod: 12h / 12h (hrs dark / hrs light)
IN-LIFE DATES: From: 09 January 2009 To: 9 March 2009.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Elemental tin was formulated as a fine suspension in 1 % (w/v) carboxymethyl cellulose (sodium salt) to a final volume of 25.3 mL at the required concentration (nominally 200 mg/mL). The formulation was mixed on a magnetic stirrer for about 20 minutes and then left to stand. It was then mixed on a magnetic stirrer immediately before and during the dosing procedure in order to ensure homogeneity.
A single daily preparation on the first day of dosing
VEHICLE
- Concentration in vehicle: 200 mg/mL
- Amount of vehicle (if gavage): 25.3 mL final volume -, administered at dose volume of 10 mL/kg bw
HOMOGENEITY AND STABILITY OF TEST MATERIAL: maintained by continuous stirring - Duration and frequency of treatment / exposure:
- Single oral administration on day 1
Doses / concentrations
- Dose / conc.:
- 2 000 mg/kg bw/day
- No. of animals per sex per dose / concentration:
- Three males and three females treated and one of each sex given vehicle alone as a concurrent control
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- No further information
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled: urine, faeces, blood, cage washes, diet, water and residual carcass
- Time and frequency of sampling: Urine and faeces were collected over approximately 24 hours prior to dosing and at the following intervals after dose administration: 0-8, 8-24, 24-48, 48-72, 72-96, 96-120, 120-144 and 144-168 hours
- Method type(s) for identification: ICP-MS for urine samples and ICP-AES for all other analyses.
- Limits of detection and quantification:
ICP-MS: The lower limit of quantification (LLOQ) was defined as the lowest non-zero standard concentration (0.02 ng/mL) providing it meets the acceptance criteria; sample results falling below the LLOQ are reported asICP-AES: The lower limit of quantification (LLOQ) was defined as the lowest non-zero standard concentration (0.05 μg/mL); sample results falling below the LLOQ are reported as - Statistics:
- Tin content in the urine samples was calculated as follows:
Urine tin content (μg/g) = instrument result (ng/mL) x 50/weight of urine sub sample (g)
Urine tin content (μg) = Urine tin content (μg/g) x total urine weight (g)
Tin content in the faeces/carcass/cage wash/cage debris samples was calculated as follows:
Tin content (mg) = (instrument result (μg/mL)/2 (Assuming sample did not require further dilution after the preparation stage (final volume equivalent to 500 mL))
Results and discussion
Main ADME resultsopen allclose all
- Type:
- excretion
- Results:
- 96.9 and 99.7 % in the faeces
- Type:
- excretion
- Results:
- The majority of excretion occured 8 and 24 hours post-dosing (mean values of 82.5 and 88.9 % recovered in the faeces)
- Type:
- absorption
- Results:
- Due to the rapid excretion via the faeces, negligible absorption through the GI tract is anticipated.
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Not applicable
- Details on distribution in tissues:
- Not applicable
Transfer into organs
- Transfer type:
- secretion via gastric mucosa
- Observation:
- no transfer detectable
- Remarks:
- Almost the entire dose was excreted in the faeces. Most of the remainder was recovered from cage washes and cage debris and suggests that these small amounts were also faecal in origin
- Details on excretion:
- The analytical results address the rates and routes of excretion of elemental tin after oral administration of a suspension of metallic tin powder with a particle size distribution in the range of 2-11 µm. Lower limits of detection were 0.02 ng/mL for urine (0.02 ppb) and 0.5 µg/mL (0.05 ppm) for all other samples.
Following oral administration of elemental tin powder at a nominal dose level of 2000 mg/kg to male rats, the overall mean recovery was 98.6 % of the administered dose over the 168 hour study period, individual recoveries ranging between 96.9 and 99.7 %. With the exception of minor amounts being recovered in the cage debris and cages washes, most of the tin was recovered in the faeces (mean of 98.3 %, individual recoveries ranging between 96.1 and 99.7 %). It seems likely that the tin recovered in the cage washes and debris was also derived from faecal material. A mean cumulative total of 10.4% of the dosed material was excreted in the faeces during the first 8 hours post dose, rising to 82.5 % at 24 hours and 96.7 % within 48 hours. Most of the remaining dosed material (1.57 %) was also recovered in this matrix. No significant levels of tin were recovered from the male rat that received a single oral administration of the dose vehicle only.
It should be noted that the lower limits of detection were more sensitive for urine analysis and very low, but detectable levels of tin were apparent in this matrix for all of the treated rats. Mean levels of tin reached a peak in the male animals at 24 hours (0.00101 % and remained relatively static at 48 and 72 hours (0.00082 and 0.00088 %, respectively). Thereafter, levels declined reaching 0.00009% at 168 hours post-dose. Over the study period total absorption was <0.004 % of the administered dose. Levels of tin were negligible in the male control animal.
A similar pattern of excretion was noted in the female rats. The mean total recovery of the administered dose was 98.5 % with individual recoveries ranging between 97.7 and 99.6 %. With the exception of a minor amount of tin recovered in the cage washes (<0.1 % of the administered dose) most dosed material was harvested from the faeces. For the females, the highest mean output of dosed material in the faeces was between dosing and 48 hours post-dose (total of 0.01 % at 8 hours, 88.9 % at 24 hours and 98.2 % at 48 hours). No significant levels of tin were detected in the female animal that received a single administration of the dose vehicle alone.
As with the male animals, tin was also detected at low levels in the urine of the females. Mean levels were generally lower than in males, reaching a peak of 0.00059 % at 24 hours and then declining to 0.00017 and 0.00022 % at 48 and 72 hours, respectively. Levels then continued to decline to 0.00003 % of the administered dose at the 168 hours sampling time. Peak levels of tin measured in the urine of the control female animal were also negligible.
Very low, but measurable concentrations of tin in the urine suggest that there may have been some low level of absorption of the dosed material. However, it must also be considered that the urine may have been slightly contaminated by the particularly high levels in the faeces during the collecting process in the metabolism cages.
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- Not relevant for metallic tin
Any other information on results incl. tables
During the course of the study, no overt pharmacological or toxicological signs that could have been attributed to the administration of the test material were observed in the test animals.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: no bioaccumulation potential based on study results of rapid and almost complete faecal excretion
After administration of elemental tin powder to male and female albino rats, the overall recoveries ranged between 96.9 and 99.7 % of the administered material. Excretion patterns were similar for both male and female animals. Almost the entire administered dose was excreted in the faeces. - Executive summary:
Elemental tin powder was orally administered to male and female albino rats at dose levels up to 2000 mg/kg bw and excreta samples collected over seven days. The overall recoveries ranged between 96.9 and 99.7 % of the administered material. Excretion patterns were similar for both male and female animals. Almost the entire administered dose was excreted in the faeces. The remaining recoveries were considered to arise from faecal contamination of urine, cages or cage wash. The major period for faecal tin output was between 8 and 24 hours post-dosing when mean values of 82.5 and 88.9 % of the dose were recovered for male and female rats respectively.
Small amounts of tin were also recovered in the urine, suggesting that some absorption of test related material may have occurred. However, this small amount could equally be due to cross-contamination from the faeces.
No significant levels of tin were collected from control animals, which received dose vehicle only, suggesting that levels of endogenous material were negligible.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.